4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-23-003481
President, CMO sold 13,280 shares at $6.12 ($81,274)
- President, CMO acquired 37,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Huang Jane President, CMO | 2023-04-04 | Option exercise | +37,500 | 37,500 | D | ||
| Huang Jane President, CMO | 2023-04-06 | Sale | −13,280 | $6.12 | $81,274 | 24,220 | D |
| Derivatives | |||||||
| Huang Jane President, CMO | 2023-04-04 | Option exercise · Restricted Stock Unit | −37,500 | 112,500 | D | ||
| Open-market sales · 13,280 sh · avg $6.12 · $81,274 | |||||||
Loading xslF345X04/primarydocument.xml…